Agilent Technologies Inc (A)

NYSE
172.40
-0.37(-0.21%)
Pre Market
172.00
-0.40(-0.23%)
- Real-time Data
  • Volume:
    816,193
  • Bid/Ask:
    170.95/177.00
  • Day's Range:
    171.20 - 173.08

A Overview

Prev. Close
172.77
Day's Range
171.2-173.08
Revenue
6.14B
Open
172.09
52 wk Range
98.12-179.57
EPS
3.21
Volume
816,193
Market Cap
52.19B
Dividend (Yield)
0.78
(0.45%)
Average Vol. (3m)
1,715,319
P/E Ratio
53.71
Beta
1.01
1-Year Change
76.48%
Shares Outstanding
302,722,668
Next Earnings Date
Nov 22, 2021
What is your sentiment on Agilent Technologies Inc?
or
Market is currently closed. Voting is open during market hours.

Agilent Technologies Inc News

Agilent Technologies Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellBuyStrong Buy
Technical IndicatorsSellStrong BuyStrong SellStrong SellStrong Buy
SummaryStrong SellStrong SellStrong SellNeutralStrong Buy

Agilent Technologies Inc Company Profile

Agilent Technologies Inc Company Profile

Agilent Technologies, Inc. provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. The Company’s business segments include life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business. The life sciences and applied markets business segment provides application-focused solutions that include instruments and software. The Company's diagnostics and genomics business segment includes the genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership and biomolecular analysis businesses. The Company's Agilent CrossLab business segment spans the entire lab with its consumables and services portfolio.

Read More
  • Ackman sold. 90 RSI. Pullback time
    0
    • it will go $158 in next 2 months
      0
      • it will go $158 in next 2 months
        0
        • TUSK will double the price very soon..Very low volume.. Don't miss it.. Good luck guys..
          0
          • Can anyone tell me if the YATSEN Ticket ysg is a good bet. It entered the IPO Thursday and is $ 17 now.
            0
            • the earning beat analyst's expectation..but why the shares lost 2.67% after hour trade??
              0
              • Beem wondering about that as well.. The only negative thing I can think of is this:Agilent Technologies doesn’t discuss specific guidance details in its current earnings report. That’s likely due to the novel coronavirus. Many companies are withholding outlooks at this time.https://www.google.com/amp/s/investorplace.com/2020/08/agilent-technologies-earnings-drop-a-stock/amp/
                0
              • A lot of times there is a "run up" to ER. This can push the stock price too high before earnings come out. Then no matter what the stock drops after the report. A good ER doesn't always guarantee the stock will go up, especially if it has a huge run up like this one did.
                0
            • Go agilent!
              0
              Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
              Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.